Expansion of clinical trial enrollment criteria: what would we gain?
In 2017, the American Society of Clinical Oncology and the non-profit organization Friends of Cancer Research noted in their joint statement that trial enrollment criteria should strive for inclusiveness to make trial populations more representative and to maximize generalizability of findings. Also, this would enable more patients to participate and accelerate accrual, resulting in expedited availability of new therapies.